Most importantly, αPD-L1 Ab combined with NPs-Stattic-IL20RA significantly inhibited the tumor volume and tumor weight of 4T1-IL20RA allografts compared with IgG, αPD-L1 Ab, NPs-Stattic, and NP-Stattic-IL20RA plus IgG treatment groups, respectively (Figure 6B-D). Here, IL20RA is linked to neoplasm.